Page last updated: 2024-11-05

vesnarinone and Carcinoma, Hepatocellular

vesnarinone has been researched along with Carcinoma, Hepatocellular in 1 studies

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"Vesnarinone has also been reported to inhibit both nucleoside and nucleobase transport."5.30Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines. ( Kato, A; Kubo, K; Matsuzaki, Y; Okita, K; Terai, S, 1999)
"Vesnarinone has also been reported to inhibit both nucleoside and nucleobase transport."1.30Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines. ( Kato, A; Kubo, K; Matsuzaki, Y; Okita, K; Terai, S, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kubo, K1
Matsuzaki, Y1
Kato, A1
Terai, S1
Okita, K1

Other Studies

1 other study available for vesnarinone and Carcinoma, Hepatocellular

ArticleYear
Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
    International journal of oncology, 1999, Volume: 14, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Dose-Response Relationsh

1999